OtherBasic Science (Animal or Phantoms)
99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET
Filipe Elvas, Jan Boddaert, Christel Vangestel, Koon Pak, Brian Gray, Samir Kumar-Singh, Steven Staelens, Sigrid Stroobants and Leonie wyffels
Journal of Nuclear Medicine November 2016, jnumed.116.182014; DOI: https://doi.org/10.2967/jnumed.116.182014
Filipe Elvas
1 University of Antwerp, Belgium;
Jan Boddaert
1 University of Antwerp, Belgium;
Christel Vangestel
1 University of Antwerp, Belgium;
Koon Pak
2 Molecular Targeting Technologies, Inc., United States;
Brian Gray
2 Molecular Targeting Technologies, Inc., United States;
Samir Kumar-Singh
1 University of Antwerp, Belgium;
Steven Staelens
3 Antwerp University, Belgium;
Sigrid Stroobants
4 University Hospital Antwerp, Belgium
Leonie wyffels
4 University Hospital Antwerp, Belgium
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET
Filipe Elvas, Jan Boddaert, Christel Vangestel, Koon Pak, Brian Gray, Samir Kumar-Singh, Steven Staelens, Sigrid Stroobants, Leonie wyffels
Journal of Nuclear Medicine Nov 2016, jnumed.116.182014; DOI: 10.2967/jnumed.116.182014
99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET
Filipe Elvas, Jan Boddaert, Christel Vangestel, Koon Pak, Brian Gray, Samir Kumar-Singh, Steven Staelens, Sigrid Stroobants, Leonie wyffels
Journal of Nuclear Medicine Nov 2016, jnumed.116.182014; DOI: 10.2967/jnumed.116.182014